Matched Signals
No stored keyword or signal matches were recorded for this activity window.
Correspondence Activity Detail
Liminatus Pharma, Inc. (LIMN)
Activity window: Sep. 25, 2025 to Sep. 24, 2026
Filings In This Window
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Feb. 11, 2026 | CORRESP | Neutral/Informational | Moderate | Liminatus Pharma, Inc. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have the stat… | Read Filing EDGAR |
| Feb. 11, 2026 | CORRESP | Neutral/Informational | Moderate | Liminatus Pharma, Inc. has submitted a request for the acceleration of the effective date of their Registration Statement on Form S-1. The request, made by Maxim Group LLC as the … | Read Filing EDGAR |
| Jan. 6, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Liminatus Pharma, Inc. that it does not intend to review their draft registration statement submitted on December 31, 2025. The SEC has requested that … | Read Filing EDGAR |
Notable 8-Ks In This Window
No notable 8-Ks were stored for this company in this activity window.